D Janowsky
Overview
Explore the profile of D Janowsky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garbutt J, Janowsky D
Am J Psychiatry
. 1997 Feb;
154(2):269-70.
PMID: 9016281
Objective: The purpose of this study was to test in humans the finding from animal studies indicating an association between preference for more concentrated sweet solutions and excessive alcohol drinking....
2.
Rezvani A, Pucilowski O, Grady D, Janowsky D, OBrien R
Pharmacol Biochem Behav
. 1993 Oct;
46(2):365-71.
PMID: 8265691
Neuronal Ca2+ channels have been shown to be involved in both alcohol drinking behavior in rats and nonhuman primates and in the manifestation of alcohol withdrawal symptoms in rodents. Experiments...
3.
Morgan D, Overstreet D, Janowsky D
Synapse
. 1991 Dec;
9(4):251-301.
PMID: 1685032
The present document is the second of three parts in a review that focuses on recent data from clinical and animal research concerning the biochemical bases of depressive disorders, diagnosis,...
4.
Gillin J, Sutton L, Ruiz C, Darko D, Golshan S, Risch S, et al.
Biol Psychiatry
. 1991 Jul;
30(2):157-69.
PMID: 1655072
In order to determine the effect of an anticholinergic agent on mood and sleep, scopolamine (0.4 mg IM) was administered before bedtime for three consecutive nights to 10 depressed patients...
5.
Rapaport M, Risch S, Gillin J, Golshan S, Janowsky D
Biol Psychiatry
. 1991 Apr;
29(7):658-64.
PMID: 2054436
Nine patients who met both DSM-III and RDC criteria for panic disorder and nine age-matched normal controls received infusions of physostigmine. The patients and normal controls did not differ in...
6.
Gillin J, Sutton L, Ruiz C, Kelsoe J, DUPONT R, Darko D, et al.
Arch Gen Psychiatry
. 1991 Mar;
48(3):264-70.
PMID: 1996921
The cholinergic rapid eye movement (REM) induction test using arecoline hydrobromide, a cholinergic muscarinic receptor agonist, was studied in patients with affective disorder and in normal controls to determine whether...
7.
CONANT J, Engler R, Janowsky D, Maisel A, Gilpin E, LeWinter M
J Cardiovasc Pharmacol
. 1989 Apr;
13(4):656-61.
PMID: 2471005
beta-adrenergic blocking agents have undesirable effects believed to be mediated through the central nervous system (CNS). If these effects are due to direct CNS action, less lipid soluble agents ought...
8.
Janowsky D, Risch S, Ziegler M, Gillin J
Mil Med
. 1987 Nov;
152(11):579-81.
PMID: 3122083
No abstract available.
9.
Wolfe J, Granholm E, Butters N, Saunders E, Janowsky D
J Affect Disord
. 1987 Jul;
13(1):83-92.
PMID: 2959704
The verbal learning and fluency of patients with unipolar and bipolar depression were compared to those of normal controls and patients with Huntington's disease. The data demonstrated that the recall...
10.
Zisook S, MENDELS J, Janowsky D, Feighner J, Lee J, Fritz A
Neuropsychobiology
. 1987 Jan;
17(3):133-8.
PMID: 3683802
Forty-two outpatients with major depressive disorder were treated with oral fezolamine in a 6-week, three-center open-label study. Therapy was initiated at 100 mg/day; thereafter dosage was increased based on the...